• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For February 28, 2022

    2/28/22 4:17:09 AM ET
    $AAON
    $ACAD
    $ACHC
    $AGM
    Industrial Machinery/Components
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAON alert in real time by email

     

    Companies Reporting Before The Bell

    • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.

    • Praxis Precision Medicine (NASDAQ:PRAX) is likely to report earnings for its fourth quarter.

    • Blackstone Secured (NYSE:BXSL) is likely to report quarterly earnings at $0.59 per share on revenue of $171.69 million.

    • Mersana Therapeutics (NASDAQ:MRSN) is estimated to report earnings for its fourth quarter.

    • Partner Communications Co (NASDAQ:PTNR) is expected to report earnings for its fourth quarter.

    • Daqo New Energy (NYSE:DQ) is expected to report quarterly earnings at $4.58 per share on revenue of $698.65 million.

    • Easterly Government Props (NYSE:DEA) is likely to report quarterly earnings at $0.10 per share on revenue of $72.20 million.

    • Aurinia Pharmaceuticals (NASDAQ:AUPH) is expected to report earnings for its fourth quarter.

    • Kosmos Energy (NYSE:KOS) is estimated to report quarterly earnings at $0.15 per share on revenue of $380.81 million.

    • Verso (NYSE:VRS) is estimated to report quarterly earnings at $0.66 per share on revenue of $298.41 million.

    • Tegna (NYSE:TGNA) is likely to report quarterly earnings at $0.55 per share on revenue of $772.59 million.

    • FREYR Battery (NYSE:FREY) is expected to report earnings for its fourth quarter.

    • Cano Health (NYSE:CANO) is estimated to report quarterly loss at $0.02 per share on revenue of $531.65 million.

    • Butterfly Network (NYSE:BFLY) is projected to report quarterly loss at $0.26 per share on revenue of $17.00 million.

    • Lordstown Motors (NASDAQ:RIDE) is estimated to report earnings for its fourth quarter.

    • XPEL (NASDAQ:XPEL) is projected to report quarterly earnings at $0.30 per share on revenue of $69.21 million.

    • Viatris (NASDAQ:VTRS) is projected to report quarterly earnings at $0.83 per share on revenue of $4.35 billion.

    • Global Partners (NYSE:GLP) is expected to report quarterly earnings at $0.23 per share on revenue of $3.99 billion.

    • National Vision Holdings (NASDAQ:EYE) is estimated to report quarterly loss at $0.02 per share on revenue of $459.56 million.

    • Reata Pharmaceuticals (NASDAQ:RETA) is likely to report quarterly loss at $2.31 per share on revenue of $1.63 million.

    • HNI (NYSE:HNI) is estimated to report quarterly earnings at $0.41 per share on revenue of $596.63 million.

    • Fomento Economico (NYSE:FMX) is likely to report quarterly earnings at $1.11 per share on revenue of $6.99 billion.

    • Alcon (NYSE:ALC) is estimated to report quarterly earnings at $0.62 per share on revenue of $170.00 million.

    • Cactus (NYSE:WHD) is projected to report quarterly earnings at $0.20 per share on revenue of $123.26 million.

    • Itron (NASDAQ:ITRI) is expected to report quarterly earnings at $0.19 per share on revenue of $505.76 million.

    • Heska (NASDAQ:HSKA) is estimated to report quarterly loss at $0.04 per share on revenue of $65.62 million.

    • VEON (NASDAQ:VEON) is expected to report quarterly earnings at $0.08 per share on revenue of $2.01 billion.

    • Dentsply Sirona (NASDAQ:XRAY) is estimated to report quarterly earnings at $0.79 per share on revenue of $1.13 billion.

    • Astec Industries (NASDAQ:ASTE) is likely to report quarterly earnings at $0.02 per share on revenue of $267.89 million.

    • Civeo (NYSE:CVEO) is expected to report earnings for its fourth quarter.

    • Nielsen Holdings (NYSE:NLSN) is estimated to report quarterly earnings at $0.35 per share on revenue of $898.13 million.

    • Party City Holdco (NYSE:PRTY) is projected to report quarterly earnings at $0.40 per share on revenue of $697.25 million.

    • Jones Lang LaSalle (NYSE:JLL) is likely to report quarterly earnings at $6.81 per share on revenue of $2.56 billion.

    • Clearway Energy (NYSE:CWEN) is expected to report earnings for its fourth quarter.

    • Enel Chile (NYSE:ENIC) is expected to report earnings for its fourth quarter.

    • Itau Corpbanca (NYSE:ITCB) is projected to report earnings for its fourth quarter.

     

    Companies Reporting After The Bell

    • Asensus Surgical (AMEX:ASXC) is estimated to report quarterly loss at $0.07 per share on revenue of $1.51 million.

    • Ocular Therapeutix (NASDAQ:OCUL) is estimated to report quarterly loss at $0.23 per share on revenue of $14.44 million.

    • Atea Pharmaceuticals (NASDAQ:AVIR) is expected to report quarterly earnings at $0.17 per share on revenue of $85.73 million.

    • Lucid Gr (NASDAQ:LCID) is estimated to report quarterly loss at $0.35 per share on revenue of $36.74 million.

    • Revolution Medicines (NASDAQ:RVMD) is expected to report quarterly loss at $0.64 per share on revenue of $8.92 million.

    • Supernus Pharmaceuticals (NASDAQ:SUPN) is estimated to report quarterly earnings at $0.24 per share on revenue of $149.42 million.

    • Heron Therapeutics (NASDAQ:HRTX) is projected to report quarterly loss at $0.58 per share on revenue of $25.59 million.

    • Pennant Group (NASDAQ:PNTG) is expected to report quarterly earnings at $0.15 per share on revenue of $109.74 million.

    • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.04 per share on revenue of $269.80 million.

    • UserTesting (NYSE:USER) is expected to report quarterly loss at $0.18 per share on revenue of $39.01 million.

    • Revance Therapeutics (NASDAQ:RVNC) is likely to report quarterly loss at $1.02 per share on revenue of $24.27 million.

    • Preferred Apartment (NYSE:APTS) is projected to report quarterly loss at $0.65 per share on revenue of $102.02 million.

    • Apellis Pharmaceuticals (NASDAQ:APLS) is likely to report quarterly loss at $1.54 per share on revenue of $8.78 million.

    • Ardelyx (NASDAQ:ARDX) is estimated to report quarterly loss at $0.30 per share on revenue of $700.00 thousand.

    • Sterling Construction Co (NASDAQ:STRL) is projected to report quarterly earnings at $0.37 per share on revenue of $337.60 million.

    • Darling Ingredients (NYSE:DAR) is projected to report quarterly earnings at $0.88 per share on revenue of $1.22 billion.

    • Shenandoah (NASDAQ:SHEN) is likely to report quarterly earnings at $0.04 per share on revenue of $62.92 million.

    • Commercial Vehicle Group (NASDAQ:CVGI) is expected to report quarterly earnings at $0.17 per share on revenue of $221.75 million.

    • Global Cord Blood (NYSE:CO) is projected to report earnings for its third quarter.

    • Novavax (NASDAQ:NVAX) is estimated to report quarterly loss at $1.80 per share on revenue of $331.79 million.

    • Kyndryl Hldgs (NYSE:KD) is projected to report quarterly loss at $0.47 per share on revenue of $4.54 billion.

    • Aris Water Solutions (NYSE:ARIS) is projected to report quarterly earnings at $0.14 per share on revenue of $64.69 million.

    • Rocket Lab USA (NASDAQ:RKLB) is projected to report quarterly loss at $0.05 per share on revenue of $24.17 million.

    • New Mountain Finance (NASDAQ:NMFC) is estimated to report quarterly earnings at $0.30 per share on revenue of $66.69 million.

    • Nerdy (NYSE:NRDY) is projected to report quarterly loss at $0.09 per share on revenue of $41.64 million.

    • Gulfport Energy (NYSE:GPOR) is estimated to report quarterly earnings at $5.03 per share on revenue of $318.97 million.

    • TaskUs (NASDAQ:TASK) is estimated to report quarterly earnings at $0.33 per share on revenue of $216.01 million.

    • Quantum-Si (NASDAQ:QSI) is projected to report earnings for its fourth quarter.

    • Luminar Technologies (NASDAQ:LAZR) is expected to report quarterly loss at $0.11 per share on revenue of $11.83 million.

    • Radius Global Infr (NASDAQ:RADI) is estimated to report quarterly loss at $0.30 per share on revenue of $29.52 million.

    • SEMrush Hldgs (NYSE:SEMR) is expected to report quarterly loss at $0.04 per share on revenue of $52.12 million.

    • Seer (NASDAQ:SEER) is projected to report quarterly loss at $0.32 per share on revenue of $2.23 million.

    • Celldex Therapeutics (NASDAQ:CLDX) is expected to report quarterly loss at $0.42 per share on revenue of $1.04 million.

    • Vaxcyte (NASDAQ:PCVX) is expected to report earnings for its fourth quarter.

    • Canoo (NASDAQ:GOEV) is projected to report earnings for its fourth quarter.

    • Danimer Scientific (NYSE:DNMR) is likely to report quarterly loss at $0.30 per share on revenue of $17.87 million.

    • Blink Charging (NASDAQ:BLNK) is estimated to report quarterly loss at $0.39 per share on revenue of $5.43 million.

    • Montrose Environmental Gr (NYSE:MEG) is expected to report quarterly loss at $0.06 per share on revenue of $121.98 million.

    • BioLife Solutions (NASDAQ:BLFS) is expected to report quarterly loss at $0.17 per share on revenue of $35.81 million.

    • GoodRx Holdings (NASDAQ:GDRX) is likely to report quarterly earnings at $0.10 per share on revenue of $217.46 million.

    • ON24 (NYSE:ONTF) is likely to report quarterly loss at $0.09 per share on revenue of $51.66 million.

    • comScore (NASDAQ:SCOR) is projected to report quarterly loss at $0.12 per share on revenue of $97.02 million.

    • Surgery Partners (NASDAQ:SGRY) is likely to report quarterly earnings at $0.19 per share on revenue of $621.74 million.

    • Oak Street Health (NYSE:OSH) is estimated to report quarterly loss at $0.57 per share on revenue of $393.53 million.

    • SI-BONE (NASDAQ:SIBN) is projected to report quarterly loss at $0.39 per share on revenue of $24.70 million.

    • MiMedx Group (NASDAQ:MDXG) is estimated to report quarterly loss at $0.03 per share on revenue of $63.69 million.

    • Castle Biosciences (NASDAQ:CSTL) is projected to report quarterly loss at $0.47 per share on revenue of $23.74 million.

    • SmileDirectClub (NASDAQ:SDC) is estimated to report quarterly loss at $0.27 per share on revenue of $127.71 million.

    • Vroom (NASDAQ:VRM) is estimated to report quarterly loss at $0.77 per share on revenue of $901.91 million.

    • Verra Mobility (NASDAQ:VRRM) is expected to report quarterly earnings at $0.22 per share on revenue of $158.34 million.

    • NV5 Global (NASDAQ:NVEE) is likely to report quarterly earnings at $1.04 per share on revenue of $186.32 million.

    • Hanger (NYSE:HNGR) is estimated to report quarterly earnings at $0.44 per share on revenue of $315.45 million.

    • Helios Technologies (NYSE:HLIO) is estimated to report quarterly earnings at $0.83 per share on revenue of $204.80 million.

    • Gaia (NASDAQ:GAIA) is expected to report quarterly earnings at $0.03 per share on revenue of $20.87 million.

    • FS KKR Capital (NYSE:FSK) is expected to report quarterly earnings at $0.61 per share on revenue of $343.37 million.

    • Atara Biotherapeutics (NASDAQ:ATRA) is estimated to report quarterly loss at $0.69 per share on revenue of $35.14 million.

    • FibroGen (NASDAQ:FGEN) is expected to report quarterly loss at $0.66 per share on revenue of $47.65 million.

    • Arcturus Therapeutics (NASDAQ:ARCT) is expected to report quarterly loss at $1.72 per share on revenue of $14.72 million.

    • Mirati Therapeutics (NASDAQ:MRTX) is estimated to report quarterly loss at $3.00 per share on revenue of $1.25 million.

    • Velodyne Lidar (NASDAQ:VLDR) is expected to report quarterly loss at $0.17 per share on revenue of $16.65 million.

    • SailPoint Technologies (NYSE:SAIL) is expected to report quarterly loss at $0.06 per share on revenue of $113.74 million.

    • PRA Group (NASDAQ:PRAA) is likely to report quarterly earnings at $0.66 per share on revenue of $252.55 million.

    • Nelnet (NYSE:NNI) is estimated to report quarterly earnings at $2.23 per share on revenue of $336.25 million.

    • Nektar Therapeutics (NASDAQ:NKTR) is likely to report quarterly loss at $0.81 per share on revenue of $25.33 million.

    • James River Gr Hldgs (NASDAQ:JRVR) is likely to report quarterly earnings at $0.12 per share on revenue of $198.57 million.

    • Dynavax Technologies (NASDAQ:DVAX) is estimated to report quarterly earnings at $0.69 per share on revenue of $208.87 million.

    • Broadmark Realty Capital (NYSE:BRMK) is estimated to report quarterly earnings at $0.21 per share on revenue of $33.95 million.

    • Valens Co (NASDAQ:VLNS) is projected to report quarterly loss at $0.12 per share on revenue of $20.64 million.

    • Progyny (NASDAQ:PGNY) is estimated to report quarterly earnings at $0.04 per share on revenue of $136.08 million.

    • PDC Energy (NASDAQ:PDCE) is likely to report quarterly earnings at $2.55 per share on revenue of $671.52 million.

    • icad (NASDAQ:ICAD) is projected to report quarterly loss at $0.11 per share on revenue of $8.39 million.

    • Fate Therapeutics (NASDAQ:FATE) is likely to report quarterly loss at $0.67 per share on revenue of $10.73 million.

    • Enviva (NYSE:EVA) is projected to report quarterly earnings at $0.26 per share on revenue of $332.02 million.

    • PubMatic (NASDAQ:PUBM) is projected to report quarterly earnings at $0.27 per share on revenue of $75.54 million.

    • Primoris Services (NASDAQ:PRIM) is likely to report quarterly earnings at $0.56 per share on revenue of $892.94 million.

    • Forum Energy Technologies (NYSE:FET) is estimated to report quarterly loss at $0.80 per share on revenue of $150.00 million.

    • Freshpet (NASDAQ:FRPT) is estimated to report quarterly loss at $0.16 per share on revenue of $116.45 million.

    • Centerspace (NYSE:CSR) is likely to report quarterly loss at $0.45 per share on revenue of $53.48 million.

    • BigCommerce Holdings (NASDAQ:BIGC) is expected to report quarterly loss at $0.12 per share on revenue of $61.82 million.

    • Veracyte (NASDAQ:VCYT) is estimated to report quarterly loss at $0.16 per share on revenue of $61.78 million.

    • AVITA Medical (NASDAQ:RCEL) is expected to report quarterly loss at $0.39 per share on revenue of $7.00 million.

    • Otonomy (NASDAQ:OTIC) is likely to report earnings for its fourth quarter.

    • MBIA (NYSE:MBI) is likely to report quarterly loss at $0.44 per share on revenue of $11.00 million.

    • CrossAmerica Partners (NYSE:CAPL) is likely to report quarterly earnings at $0.21 per share on revenue of $732.98 million.

    • AppFolio (NASDAQ:APPF) is estimated to report quarterly loss at $0.02 per share on revenue of $92.53 million.

    • Ameresco (NYSE:AMRC) is projected to report quarterly earnings at $0.42 per share on revenue of $410.13 million.

    • Ambarella (NASDAQ:AMBA) is expected to report quarterly earnings at $0.42 per share on revenue of $90.16 million.

    • Tetra Technologies (NYSE:TTI) is likely to report earnings for its fourth quarter.

    • Howard Hughes (NYSE:HHC) is projected to report quarterly earnings at $1.63 per share on revenue of $123.70 million.

    • Federal Agricultural (NYSE:AGM) is expected to report earnings for its fourth quarter.

    • AAON (NASDAQ:AAON) is estimated to report quarterly earnings at $0.28 per share on revenue of $136.62 million.

    • Stoneridge (NYSE:SRI) is expected to report quarterly loss at $0.24 per share on revenue of $180.03 million.

    • 3D Sys (NYSE:DDD) is likely to report quarterly earnings at $0.04 per share on revenue of $144.18 million.

    • ACADIA Pharmaceuticals (NASDAQ:ACAD) is expected to report quarterly loss at $0.24 per share on revenue of $135.60 million.

    • Trex Co (NYSE:TREX) is estimated to report quarterly earnings at $0.53 per share on revenue of $302.51 million.

    • Heidrick & Struggles Intl (NASDAQ:HSII) is expected to report quarterly earnings at $0.79 per share on revenue of $261.40 million.

    • Zoom Video Communications (NASDAQ:ZM) is expected to report quarterly earnings at $1.05 per share on revenue of $1.05 billion.

    • Groupon (NASDAQ:GRPN) is projected to report quarterly earnings at $0.19 per share on revenue of $223.53 million.

    • Workday (NASDAQ:WDAY) is estimated to report quarterly earnings at $0.71 per share on revenue of $1.36 billion.

    • Endo International (NASDAQ:ENDP) is likely to report quarterly earnings at $0.67 per share on revenue of $731.40 million.

    • Acadia Healthcare Co (NASDAQ:ACHC) is estimated to report quarterly earnings at $0.68 per share on revenue of $588.05 million.

    • SBA Communications (NASDAQ:SBAC) is projected to report quarterly earnings at $0.69 per share on revenue of $591.27 million.

    • ONEOK (NYSE:OKE) is estimated to report quarterly earnings at $0.89 per share on revenue of $4.34 billion.

    • HP (NYSE:HPQ) is expected to report quarterly earnings at $1.02 per share on revenue of $16.52 billion.

    • Hyster-Yale Materials (NYSE:HY) is likely to report quarterly loss at $1.10 per share on revenue of $786.15 million.

    • Semler Scientific (NASDAQ:SMLR) is expected to report earnings for its fourth quarter.

    • Global Medical REIT (NYSE:GMRE) is projected to report earnings for its fourth quarter.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AAON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAON
    $ACAD
    $ACHC
    $AGM

    CompanyDatePrice TargetRatingAnalyst
    Sterling Infrastructure Inc.
    $STRL
    2/12/2026$486.00Buy
    Stifel
    Trex Company Inc.
    $TREX
    2/11/2026Buy → Hold
    The Benchmark Company
    Nektar Therapeutics
    $NKTR
    2/10/2026Mkt Perform → Outperform
    William Blair
    Kyndryl Holdings Inc.
    $KD
    2/10/2026Buy → Neutral
    Guggenheim
    Kyndryl Holdings Inc.
    $KD
    2/9/2026Outperform → Perform
    Oppenheimer
    Kyndryl Holdings Inc.
    $KD
    2/9/2026$16.00Overweight → Underweight
    Analyst
    Viatris Inc.
    $VTRS
    2/9/2026$18.00Neutral → Buy
    UBS
    Zoom Communications Inc.
    $ZM
    2/5/2026$115.00Peer Perform → Outperform
    Wolfe Research
    More analyst ratings

    $AAON
    $ACAD
    $ACHC
    $AGM
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $AAON
    $ACAD
    $ACHC
    $AGM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Sterling Infrastructure with a new price target

    Stifel initiated coverage of Sterling Infrastructure with a rating of Buy and set a new price target of $486.00

    2/12/26 7:24:54 AM ET
    $STRL
    Military/Government/Technical
    Industrials

    Trex downgraded by The Benchmark Company

    The Benchmark Company downgraded Trex from Buy to Hold

    2/11/26 6:57:04 AM ET
    $TREX
    Forest Products
    Basic Materials

    Nektar Therapeutics upgraded by William Blair

    William Blair upgraded Nektar Therapeutics from Mkt Perform to Outperform

    2/10/26 11:48:14 AM ET
    $NKTR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAON
    $ACAD
    $ACHC
    $AGM
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Workday Inc.

    SCHEDULE 13G/A - Workday, Inc. (0001327811) (Subject)

    2/12/26 9:58:50 PM ET
    $WDAY
    EDP Services
    Technology

    SEC Form 10-K filed by Avita Medical Inc.

    10-K - AVITA Medical, Inc. (0001762303) (Filer)

    2/12/26 5:20:54 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Ameresco Inc.

    144 - Ameresco, Inc. (0001488139) (Subject)

    2/12/26 4:29:18 PM ET
    $AMRC
    Engineering & Construction
    Consumer Discretionary

    $AAON
    $ACAD
    $ACHC
    $AGM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Kyndryl to Modernize Yamaguchi Financial Group's Core Banking System into a Multi‑Bank Platform

    TOKYO, Feb. 12, 2026 /PRNewswire/ -- Kyndryl (NYSE:KD), a leading provider of mission-critical enterprise technology services, today announced that it will support Yamaguchi Financial Group (Yamaguchi FG) in building an integrated platform for its core banking system. This will enable Yamaguchi FG's three banks—Yamaguchi Bank, Momiji Bank and Kitakyushu Bank—to operate on a shared IT infrastructure while consolidating application programs into a single source.   This initiative will streamline group operations and support future business expansion via an IT platform that enabl

    2/12/26 8:00:00 PM ET
    $KD
    EDP Services
    Technology

    Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026

    ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the fourth quarter and full year 2025 financial and business results on Tuesday, February 24, 2026, at 4:30 p.m. ET. Following management's prepared remarks and discussion of

    2/12/26 4:35:00 PM ET
    $SUPN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rocket Lab Prepares To Launch Latest Hypersonic Test Mission for Defense Innovation Unit

    LONG BEACH, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced its next launch is a dedicated mission on its HASTE rocket for the Department of War's Defense Innovation Unit (DIU). The mission, named Cassowary Vex, is scheduled to launch no earlier than late February from Rocket Lab Launch Complex 2 within the Virginia Spaceport Authority's Mid-Atlantic Regional Spaceport on Wallops Island, Virginia. The HASTE launch, dubbed ‘That's Not A Knife," is the latest mission of the DIU and will deploy DART AE, a scramjet-powered aircraft developed by Australian aero

    2/12/26 4:30:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $AAON
    $ACAD
    $ACHC
    $AGM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Avicenna Life Sci Master Fund Lp claimed ownership of 1,538,462 shares (SEC Form 3)

    3 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/12/26 9:29:24 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    General Counsel Pickering Evan was granted 2,648 shares and covered exercise/tax liability with 547 shares, increasing direct ownership by 39% to 7,480 units (SEC Form 4)

    4 - APPFOLIO INC (0001433195) (Issuer)

    2/12/26 7:26:47 PM ET
    $APPF
    Computer Software: Prepackaged Software
    Technology

    Amendment: SVP Sales & Marketing Leslie Dara covered exercise/tax liability with 2,528 shares and was granted 7,251 shares, increasing direct ownership by 83% to 10,396 units (SEC Form 4)

    4/A - SHENANDOAH TELECOMMUNICATIONS CO/VA/ (0000354963) (Issuer)

    2/12/26 7:22:10 PM ET
    $SHEN
    Telecommunications Equipment
    Telecommunications

    $AAON
    $ACAD
    $ACHC
    $AGM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Melnikov Dmitry bought 66,667 shares, increasing direct ownership by 4% to 1,946,479 units (SEC Form 4)

    4 - SEMrush Holdings, Inc. (0001831840) (Issuer)

    2/12/26 4:47:49 PM ET
    $SEMR
    Computer Software: Prepackaged Software
    Technology

    Chief Technology Officer Shchegolev Oleg bought 144,000 shares (SEC Form 4)

    4 - SEMrush Holdings, Inc. (0001831840) (Issuer)

    2/12/26 4:42:11 PM ET
    $SEMR
    Computer Software: Prepackaged Software
    Technology

    Director Invus Global Management, Llc was granted 22,400,000 shares, bought $2,000,001 worth of shares (1,538,462 units at $1.30) and was granted 367,145 units of Series B Convertible Preferred Stock (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/4/26 4:25:05 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAON
    $ACAD
    $ACHC
    $AGM
    Leadership Updates

    Live Leadership Updates

    View All

    Kyndryl to Modernize Yamaguchi Financial Group's Core Banking System into a Multi‑Bank Platform

    TOKYO, Feb. 12, 2026 /PRNewswire/ -- Kyndryl (NYSE:KD), a leading provider of mission-critical enterprise technology services, today announced that it will support Yamaguchi Financial Group (Yamaguchi FG) in building an integrated platform for its core banking system. This will enable Yamaguchi FG's three banks—Yamaguchi Bank, Momiji Bank and Kitakyushu Bank—to operate on a shared IT infrastructure while consolidating application programs into a single source.   This initiative will streamline group operations and support future business expansion via an IT platform that enabl

    2/12/26 8:00:00 PM ET
    $KD
    EDP Services
    Technology

    PubMatic Appoints Marketing Veteran John Petralia as Chief Marketing Officer to Accelerate AI-Driven Growth

    Appointment strengthens commercial leadership as PubMatic scales AI-powered advertising across CTV, mobile and omnichannel media. PubMatic (NASDAQ:PUBM), the leading AI-powered ad tech company delivering digital advertising performance, today announced the appointment of John Petralia as Chief Marketing Officer. Petralia will lead PubMatic's global marketing organization as the company scales AI-powered advertising technology across premium connected TV (CTV), mobile app, and omnichannel media. His appointment comes as publishers and brands move from AI experimentation to live, measurable execution – placing new emphasis on clarity, measurable performance, and trusted scalability. His

    2/12/26 8:00:00 AM ET
    $PUBM
    Computer Software: Programming Data Processing
    Technology

    Trex Company Appoints Irene Tasi to Board of Directors

    Trex Company, Inc. (NYSE:TREX), the world's largest manufacturer of wood-alternative decking and railing, today announced the appointment of Irene Tasi as a new independent member of its Board of Directors, effective immediately. Ms. Tasi brings more than 25 years of leadership experience across the global industrial and building product sectors, with particular expertise in strategic development and transformation. She currently serves as Chief Transformation Officer at PPG, a global manufacturer and distributor of paints, coatings, and specialty products, where she leads enterprise-wide transformation and growth initiatives. During her tenure at PPG, Ms. Tasi has also served as Senior V

    2/9/26 4:10:00 PM ET
    $TREX
    Forest Products
    Basic Materials

    $AAON
    $ACAD
    $ACHC
    $AGM
    Financials

    Live finance-specific insights

    View All

    Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026

    ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026. Jack Khattar, President and CEO, and Tim Dec, Senior Vice President and CFO, will host a conference call to present the fourth quarter and full year 2025 financial and business results on Tuesday, February 24, 2026, at 4:30 p.m. ET. Following management's prepared remarks and discussion of

    2/12/26 4:35:00 PM ET
    $SUPN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

    VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ:RCEL, ASX: AVH)), a leading therapeutic acute wound care company delivering transformative solutions ("AVITA Medical," or the "Company"), today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights and Recent Business Updates Total revenue of $17.6 million, compared to $18.4 million in the fourth quarter of 2024, reflecting the lingering impact of reimbursement headwinds throughout 2025.Gross profit margin of 81.2%, reflecting product mix and inventory-related adjustments.Net use of cash improved for the second consecutive quarter t

    2/12/26 4:01:00 PM ET
    $RCEL
    Medical/Dental Instruments
    Health Care

    Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

    NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using t

    2/12/26 2:46:53 PM ET
    $PGNY
    Misc Health and Biotechnology Services
    Health Care

    $AAON
    $ACAD
    $ACHC
    $AGM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Montrose Environmental Group Inc.

    SC 13G - Montrose Environmental Group, Inc. (0001643615) (Subject)

    12/17/24 4:20:32 PM ET
    $MEG
    Professional Services
    Consumer Discretionary

    SEC Form SC 13G filed by Groupon Inc.

    SC 13G - Groupon, Inc. (0001490281) (Subject)

    12/13/24 10:39:00 AM ET
    $GRPN
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care